Recruiting NA INTERVENTIONAL 2-arm NCT04412200

Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus

Randomized Controlled Study to Evaluate the Effect of Hyperbaric Oxygen Therapy (HBOT) on Treg-CD4+Cells, Cytokines Profile, and Beta Cells Reserve in New-onset Type-1 Diabetes Mellitus

Sponsor: Assaf-Harofeh Medical Center

Conditions T1DM

Interventions Hyperbaric oxygen chamber (HBOC)

Updated 5 times since 2020 Last updated: Sep 18, 2022 Started: Jun 1, 2020 Primary completion: Nov 30, 2024 Completion: May 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on T1DM, this trial is actively recruiting participants. The trial is conducted by Assaf-Harofeh Medical Center and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Sep 2022 [monthly]

Not Yet Recruiting NA
Jul 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assaf-Harofeh Medical Center

Data source: Assaf-Harofeh Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tzrifin, Israel
• Zrifin, Israel